Status:
RECRUITING
Cell Free DNA in Mature B-cell Lymphoma
Lead Sponsor:
Ruijin Hospital
Conditions:
Mature B-Cell Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor ...
Eligibility Criteria
Inclusion
- Documented diagnosis of mature B-cell tumor according to WHO 2008 criteria
- 18 years or older
Exclusion
- Chemotherapy before
- Other tumors
Key Trial Info
Start Date :
September 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04088422
Start Date
September 28 2022
End Date
December 1 2026
Last Update
February 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin hospital
Shanghai, Shanghai Municipality, China, 200025